EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

JS Smolen, R Landewe, J Bijlsma, G Burmester, K Chatzidionysiou, M Dougados, J Nam, S Ramiro, M Voshaar, R van Vollenhoven, D Aletaha, M Aringer, M Boers, CD Buckley, F Buttgereit, V Bykerk, M Cardiel, B Combe, M Cutolo, Y van Eijk-HustingsP Emery, A Finckh, C Gabay, J Gomez-Reino, L Gossec, JE Gottenberg, Mieke Hazes, T Huizinga, M Jani, D Karateev, M Kouloumas, T Kvien, ZG Li, X Mariette, I McInnes, E Mysler, P Nash, K Pavelka, G Poor, C Richez, P van Riel, A Rubbert-Roth, K Saag, J da Silva, T Stamm, T Takeuchi, R Westhovens, M de Wit, D van der Heijde

Research output: Contribution to journalArticleAcademicpeer-review

1967 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)960-977
Number of pages18
JournalAnnals of the Rheumatic Diseases
Volume76
Issue number6
DOIs
Publication statusPublished - 2017

Research programs

  • EMC MUSC-01-31-01

Cite this